Core Scientific (CORZ) financials
Core Scientific reported revenue of $440.3M over the twelve months to Jun 30, 2026 (+108.8% year on year, latest quarter), with a 42.7% gross margin and a -47.8% operating margin in its latest quarter. Read from its own SEC filings (XBRL), each period with the filing behind it.
Quarters, as filed
| Quarter ended | Revenue | Gross profit | Operating income | Net income | Filed |
|---|---|---|---|---|---|
| Jun 30, 2026 | $164.2M | $70.0M | -$78.5M | -$1.2B | Jul 28, 2026 |
| Mar 31, 2026 | $115.2M | $30.1M | -$310.4M | -$347.2M | May 6, 2026 |
| Dec 31, 2025 | $79.8M | $20.8M | -$117.5M | $216.0M | Mar 2, 2026 |
| Sep 30, 2025 | $81.1M | $3.9M | -$54.8M | -$144.0M | Mar 2, 2026 |
| Jun 30, 2025 | $78.6M | $5.0M | -$26.3M | -$936.8M | Jul 28, 2026 |
| Mar 31, 2025 | $79.5M | $8.2M | -$47.0M | $576.3M | May 6, 2026 |
| Dec 31, 2024 | $94.9M | $4.8M | -$65.4M | -$291.1M | Mar 2, 2026 |
| Sep 30, 2024 | $95.4M | -$156,000.00 | -$41.2M | -$455.3M | Mar 2, 2026 |
- Core Scientific revenue by quarter
- Core Scientific gross profit by quarter
- Core Scientific operating income by quarter
- Core Scientific net income by quarter